Edition:
United Kingdom

Xvivo Perfusion AB (XVIVO.ST)

XVIVO.ST on Stockholm Stock Exchange

92.25SEK
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
92.25kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
18,127
52-wk High
108.00kr
52-wk Low
78.25kr

Chart for

About

Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO... (more)

Overall

Beta: 0.44
Market Cap(Mil.): kr2,461.91
Shares Outstanding(Mil.): 26.19
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.16 16.44
EPS (TTM): -- -- --
ROI: -- 14.01 10.62
ROE: -- 16.85 14.20

BRIEF-Xvivo Q3 EBITDA ex-items at SEK 4.4 million

* Q3 NET SALES SEK ‍32.3​ MILLION VERSUS SEK 31.7 MILLION YEAR AGO

27 Oct 2017

BRIEF-Xvivo Perfusion's CFO Christoffer Rosenblad appointed deputy CEO

* ‍CFO CHRISTOFFER ROSENBLAD HAS BEEN APPOINTED DEPUTY CEO WITH EFFECT FROM JULY 17, 2017​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

17 Jul 2017

BRIEF-Xvivo Perfusion Q2 EBITDA ex-items down at SEK ‍6.2​ mln

* Q2 EBITDA EX-ITEMS SEK ‍6.2​ MILLION VERSUS SEK 6.9 MILLION YEAR AGO

14 Jul 2017

Earnings vs. Estimates